Skip to main content
. 2023 May 10;2023(5):CD014682. doi: 10.1002/14651858.CD014682.pub2

Hammack 2002.

Methods Double‐blind, placebo‐controlled, cross‐over, RCT
Participants Patients who had received CDDP (cisplatin) chemotherapy, and have had painful paresthaesiae for at least 1 month attributed to CDDP neuropathy.
n = 51
Interventions Nortriptyline 100 mg
Placebo
Outcomes Pain
Sleep
Quality of life
AEs
Notes Unable to ascertain pain duration ‐ inclusion criteria only says at least 1 month